Larimar Therapeutics Inc (LRMR)
7.035
-0.26
(-3.50%)
USD |
NASDAQ |
Jun 25, 16:00
7.035
0.00 (0.00%)
After-Hours: 20:00
Larimar Therapeutics Free Cash Flow: -36.32M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -36.32M |
| December 31, 2023 | -33.46M |
| September 30, 2023 | -30.79M |
| June 30, 2023 | -27.47M |
| March 31, 2023 | -27.59M |
| December 31, 2022 | -27.67M |
| September 30, 2022 | -28.92M |
| Date | Value |
|---|---|
| June 30, 2022 | -35.54M |
| March 31, 2022 | -38.76M |
| December 31, 2021 | -42.44M |
| September 30, 2021 | -44.37M |
| June 30, 2021 | -43.10M |
| March 31, 2021 | -44.49M |
| December 31, 2020 | -42.26M |
Free Cash Flow Range, Past 5 Years
-44.49M
Minimum
Mar 2021
-27.47M
Maximum
Jun 2023
-35.94M
Average
-35.93M
Median
Free Cash Flow Benchmarks
| Biogen Inc | 1.284B |
| Eli Lilly and Co | -3.896B |
| PTC Therapeutics Inc | -199.47M |
| Design Therapeutics Inc | -53.94M |
| CEL-SCI Corp | -20.40M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.41M |
| Cash from Investing (Quarterly) | -68.36M |
| Cash from Financing (Quarterly) | 162.15M |
| Free Cash Flow Per Share (Quarterly) | -0.1944 |
| Free Cash Flow Yield | -11.15% |